Back to discover
Disease

Joint Diseases

Late-stage therapeutic developmentEmerging research
1
Publications
10
Clinical trials
2014
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q4 2026.

Clinical trials

9 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
10
All trials
2
Active
7
Late-stage
6
Completed
Late-stage studies
Recently completed

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential
Recent publications
Leading journals1
  • Mediators of inflammation1
Leading researchers3
  • Poniatowski ŁA1
  • Szukiewicz D1
  • Wojdasiewicz P1
Affiliations (unnormalised)1
  • Medical University of Warsaw1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Diseases involving the JOINTS.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.